Table 3.
The relationship between the degree of skewed XCI and clinical symptoms in MDD
| MDD patient | Patient age (years) | Age of onset (years) | Disease duration (months) | HAMD | Medicine (mg/day) | |
|---|---|---|---|---|---|---|
| Total patient | Coefficient | 0.123 | −0.007 | −0.167 | 0.138 | −0.16 |
| Significance | 0.451 | 0.966 | 0.323 | 0.415 | 0.33 | |
| Adult patient | Coefficient | −0.165 | −0.029 | −0.186 | 0.41 | 0.109 |
| Significant | 0.462 | 0.896 | 0.408 | 0.058 | 0.688 | |
| Elderly patient | Coefficient | −0.147 | −0.235 | −0.385 | −0.086 | −0.321 |
| Significance | 0.586 | 0.4 | 0.157 | 0.759 | 0.145 | |
The relationship between degree of skewed XCI and clinical indicators analyzed by Spearman's correlation and Spearman's correlation was significant at p < 0.025 for age group of MDD patients.
†Positive symptoms in the PANSS
§Negative symptoms in the PANSS